vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $19.2M, roughly 1.7× CuriosityStream Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -28.1%, a 8.3% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -18.9%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-2.3M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 5.1%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CURI vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.7× larger
RXST
$32.6M
$19.2M
CURI
Growing faster (revenue YoY)
CURI
CURI
+54.7% gap
CURI
35.8%
-18.9%
RXST
Higher net margin
CURI
CURI
8.3% more per $
CURI
-19.7%
-28.1%
RXST
More free cash flow
CURI
CURI
$6.2M more FCF
CURI
$3.9M
$-2.3M
RXST
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
5.1%
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
RXST
RXST
Revenue
$19.2M
$32.6M
Net Profit
$-3.8M
$-9.2M
Gross Margin
77.5%
Operating Margin
-17.6%
-34.8%
Net Margin
-19.7%
-28.1%
Revenue YoY
35.8%
-18.9%
Net Profit YoY
-34.6%
-54.1%
EPS (diluted)
$-0.07
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
RXST
RXST
Q4 25
$19.2M
$32.6M
Q3 25
$18.4M
$30.3M
Q2 25
$19.0M
$33.6M
Q1 25
$15.1M
$37.9M
Q4 24
$14.1M
$40.2M
Q3 24
$12.6M
$35.3M
Q2 24
$12.4M
$34.9M
Q1 24
$12.0M
$29.5M
Net Profit
CURI
CURI
RXST
RXST
Q4 25
$-3.8M
$-9.2M
Q3 25
$-3.7M
$-9.8M
Q2 25
$784.0K
$-11.8M
Q1 25
$319.0K
$-8.2M
Q4 24
$-2.8M
$-5.9M
Q3 24
$-3.1M
$-6.3M
Q2 24
$-2.0M
$-6.1M
Q1 24
$-5.0M
$-9.1M
Gross Margin
CURI
CURI
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
CURI
CURI
RXST
RXST
Q4 25
-17.6%
-34.8%
Q3 25
-24.5%
-40.1%
Q2 25
2.5%
-41.6%
Q1 25
0.5%
-28.2%
Q4 24
-27.4%
-21.5%
Q3 24
-25.8%
-26.1%
Q2 24
-20.6%
-23.9%
Q1 24
-30.4%
-36.2%
Net Margin
CURI
CURI
RXST
RXST
Q4 25
-19.7%
-28.1%
Q3 25
-20.4%
-32.4%
Q2 25
4.1%
-35.0%
Q1 25
2.1%
-21.6%
Q4 24
-19.9%
-14.8%
Q3 24
-24.3%
-17.9%
Q2 24
-16.4%
-17.4%
Q1 24
-42.0%
-30.8%
EPS (diluted)
CURI
CURI
RXST
RXST
Q4 25
$-0.07
$-0.22
Q3 25
$-0.06
$-0.24
Q2 25
$0.01
$-0.29
Q1 25
$0.01
$-0.20
Q4 24
$-0.05
$-0.14
Q3 24
$-0.06
$-0.16
Q2 24
$-0.04
$-0.16
Q1 24
$-0.09
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$27.3M
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$275.7M
Total Assets
$75.7M
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
RXST
RXST
Q4 25
$27.3M
$228.1M
Q3 25
$27.8M
$227.5M
Q2 25
$28.1M
$227.5M
Q1 25
$33.4M
$229.3M
Q4 24
$32.1M
$237.2M
Q3 24
$33.2M
$237.1M
Q2 24
$39.5M
$233.3M
Q1 24
$38.8M
$125.4M
Stockholders' Equity
CURI
CURI
RXST
RXST
Q4 25
$41.5M
$275.7M
Q3 25
$47.2M
$276.0M
Q2 25
$49.8M
$278.0M
Q1 25
$58.1M
$279.3M
Q4 24
$57.8M
$281.2M
Q3 24
$62.2M
$277.3M
Q2 24
$64.8M
$275.2M
Q1 24
$67.0M
$163.9M
Total Assets
CURI
CURI
RXST
RXST
Q4 25
$75.7M
$311.8M
Q3 25
$74.7M
$308.5M
Q2 25
$78.7M
$309.0M
Q1 25
$85.3M
$313.0M
Q4 24
$86.2M
$318.6M
Q3 24
$87.6M
$310.5M
Q2 24
$90.9M
$305.5M
Q1 24
$94.6M
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
RXST
RXST
Operating Cash FlowLast quarter
$4.0M
$-1.1M
Free Cash FlowOCF − Capex
$3.9M
$-2.3M
FCF MarginFCF / Revenue
20.5%
-6.9%
Capex IntensityCapex / Revenue
0.1%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
RXST
RXST
Q4 25
$4.0M
$-1.1M
Q3 25
$4.4M
$-1.2M
Q2 25
$2.8M
$-4.4M
Q1 25
$1.9M
$-8.8M
Q4 24
$3.0M
$-4.3M
Q3 24
$2.3M
$650.0K
Q2 24
$2.2M
$-4.0M
Q1 24
$666.0K
$-9.3M
Free Cash Flow
CURI
CURI
RXST
RXST
Q4 25
$3.9M
$-2.3M
Q3 25
$-1.8M
Q2 25
$-5.9M
Q1 25
$1.8M
$-9.4M
Q4 24
$-5.1M
Q3 24
$-453.0K
Q2 24
$-5.5M
Q1 24
$-11.3M
FCF Margin
CURI
CURI
RXST
RXST
Q4 25
20.5%
-6.9%
Q3 25
-5.8%
Q2 25
-17.6%
Q1 25
12.2%
-24.8%
Q4 24
-12.7%
Q3 24
-1.3%
Q2 24
-15.9%
Q1 24
-38.2%
Capex Intensity
CURI
CURI
RXST
RXST
Q4 25
0.1%
3.5%
Q3 25
0.0%
1.9%
Q2 25
0.0%
4.6%
Q1 25
0.5%
1.5%
Q4 24
0.0%
2.1%
Q3 24
0.0%
3.1%
Q2 24
0.0%
4.4%
Q1 24
0.0%
6.7%
Cash Conversion
CURI
CURI
RXST
RXST
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURI
CURI

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons